Takeda colitis treatment drug could cause fatal brain infection says FDA
(Reuters) – An experimental drug for ulcerative colitis and Crohn’s disease from Takeda Pharmaceutical Co could pose risk of a potentially fatal brain infection called PML even though the problem has not been seen in clinical trials, staff members of the U.S. Food and Drug Administration said on Thursday. Documents about the monoclonal antibody, called […]